Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay
Status: | Completed |
---|---|
Conditions: | Healthy Studies |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - 70 |
Updated: | 8/18/2016 |
Start Date: | August 2007 |
End Date: | June 2016 |
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Pneumococcal Opsonophagocytic Assay Development.
The study will identify healthy adults who have been vaccinated against pneumococcus, and
collect blood for the purpose of developing laboratory assays.
collect blood for the purpose of developing laboratory assays.
Collect serum with antibody levels capable of killing pneumococcal bacteria from healthy
prevaccinated adults to develop OPA assays for the 13 serotypes in 13-valent pneumococcal
conjugate vaccine.
prevaccinated adults to develop OPA assays for the 13 serotypes in 13-valent pneumococcal
conjugate vaccine.
Inclusion Criteria:
- Healthy adults 18-70 years of age
- Must have received 23vPS pneumococcal vaccine
Exclusion Criteria:
- Bleeding diathesis
- Pregnancy
- Chronic disease which could be worsened by donating blood
- Receipt of blood, blood products or immune globulin within six months
We found this trial at
1
site
Click here to add this to my saved trials